CAS Medical Systems (CASM)
CAS Medical Systems Revenues: 5.409M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CASM Revenues Rankings
| Overall | 7th percentile | 4072 of 4425 |
| Sector | 25th percentile | 352 of 470 in Healthcare |
| Industry | 20th percentile | 53 of 67 in Medical Instruments & Supplies |
CASM Revenues Range, Past 5 Years
| Minimum | -1.098M | Dec 2009 |
| Maximum | 11.71M | Sep 2008 |
| Average | 7.329M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these CASM related companies
CASM News
CASMED to Announce First Quarter 2012 Financial Results and Hold Conference Call on May 8, 2012
Apr 30, 10:00AM GlobeNewswire
Apr 30, 10:00AM GlobeNewswire
$CASM forms bullish "Continuation Wedge" chart pattern. http://stks.co/36kD
about 61 days ago by RecogniaEvents
about 61 days ago by RecogniaEvents
CORRECTION -- CASMED to Announce Fourth Quarter Financial Results and Hold Conference Call on March 6, 2012
Feb 28, 1:21PM GlobeNewswire
Feb 28, 1:21PM GlobeNewswire
CASMED to Announce Fourth Quarter Financial Results and Hold Conference Call on March 6, 2012
Feb 28, 10:56AM GlobeNewswire
Feb 28, 10:56AM GlobeNewswire
CASMED's FORE-SIGHT Absolute Tissue Oximeter Gains FDA Clearance for Use on Neonatal Abdomen
Feb 27, 7:34AM Benzinga
Feb 27, 7:34AM Benzinga
CASMED's FORE-SIGHT(R) Absolute Tissue Oximeter Gains FDA Clearance for Use on Neonatal Abdomen
Feb 27, 7:30AM GlobeNewswire
Feb 27, 7:30AM GlobeNewswire
CASMED Announces Third Quarter 2011 Earnings Release Date and Conference Call Information
Nov 01, 8:30AM GlobeNewswire
Nov 01, 8:30AM GlobeNewswire
Thomas, McNerney & Partners lowers stake in CAS Medical to 28.1% from 39.1%
Sep 06, 4:21PM FlyOnTheWall
Sep 06, 4:21PM FlyOnTheWall
CASMED to Present at the Rodman & Renshaw 13th Annual Healthcare Conference
Sep 01, 11:00AM GlobeNewswire
Sep 01, 11:00AM GlobeNewswire
CAS Medical Systems (CASM) Files 6.24M Common Shelf for Selling Shareholders
Aug 30, 3:23PM Street Insider
Aug 30, 3:23PM Street Insider
CASMED Announces Second Quarter 2011 Earnings Release Date and Conference Call Information
Aug 03, 8:30AM GlobeNewswire
Aug 03, 8:30AM GlobeNewswire
$CASM CAS Medical Systems, Inc. Equity NGM Nasdaq Deficiency due 2011/11/14
about 356 days ago by canarionyc
about 356 days ago by canarionyc
Zoll Medical Corporation: Strong Growth in a Growing Medical Equipment Market http://stk.ly/a8SjU0 $ZOLL $NXTM $DXCM $SURG $CASM $HRC $CPHD
about 591 days ago by JoshuaHayes
about 591 days ago by JoshuaHayes
Commented on: "Somanetics: Medical Technology Company Worth Monitoring" http://soc.li/qlQhZ7C $SMTS $CASM $EW $COV
about 712 days ago by investbymodel
about 712 days ago by investbymodel
$SIRI upgraded by Janco to buy, PT $1.30. - http://bit.ly/doD0BP Also watching $BPOP, $CASM, $COIN
about 776 days ago by RobTheStreet
about 776 days ago by RobTheStreet
$CASM, let me know whatcha think, that thing is smokin today @WeeklyTA
about 1007 days ago by RonMexico23
about 1007 days ago by RonMexico23
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CASM | 2.04 | +0.03 | +1.50% | 27.76M |
| CASH | 20.50 | -0.14 | -0.68% | 65.40M |
| CASC | 49.03 | +0.73 | +1.51% | 543.25M |
| CASB | 0.4455 | +0.00 | +0.00% | |
| BVN | 38.71 | +0.22 | +0.57% | 9.849B |
| BUSE | 4.65 | -0.07 | -1.48% | 402.78M |
| BUR | 7.00 | -0.05 | -0.71% | |
| BUD | 68.28 | -0.34 | -0.50% | 109.66B |
| BTZ | 13.16 | +0.02 | +0.15% | |
| BTX | 4.21 | -0.05 | -1.17% | 211.85M |
